New Keto vs Mediterranean Study Shocks Scientists

Scientific concepts & nature/health phenomena presented

• Head-to-head dietary intervention for metabolic health:

  • Keto (very low-carb, high-fat)
  • Traditional Mediterranean
  • Low-fat plant-predominant (“plant-forward”)

• Measured outcomes focused on metabolic and liver physiology, especially:

  • Liver fat (fatty liver changes)
  • Insulin resistance, including tissue-specific effects (liver vs muscle)
  • Fasting glucose
  • Prediabetes remission
  • Inflammatory markers
  • Cardiovascular risk marker: apoB (apolipoprotein B)

• Study design concept: separating diet effects from weight-loss effects

  • Calories were matched and initially reduced, producing weight loss in all groups.
  • After ~10–11% body-weight loss, calories/diet were adjusted to maintain weight, so diet-related effects could be separated from further weight-loss effects.

• Implication for interpretation

  • Scale weight can be misleading: similar weight loss did not imply similar internal metabolic/liver changes.

• Reconciling conflicting trials (science-method point)

  • Differences may depend on:
    • Carbohydrate “range”
    • Participant characteristics
    • Which macronutrient changed besides carbs (notably protein)

---

Diet composition (macros) described

• Ketogenic diet

  • ~4% calories from carbs
  • ~73% calories from fat
  • Also reported: comparatively higher protein than the other groups

• Traditional Mediterranean diet

  • ~50% calories from carbs
  • ~35% calories from fat
  • Foods described: fruits/vegetables, fish, white meats, olive oil, nuts/seeds, whole grains (e.g., oats)

• Low-fat plant-predominant (“plant-forward”)

  • ~70% calories from carbs
  • ~15% calories from fat
  • Plant-rich (not fully vegan), similar to Mediterranean but with more carbs and less fat

---

Methodology / trial design elements (as described)

• Population: “pretty unhealthy” participants:

  • Obese
  • Pre-diabetic
  • Fatty liver

• Random assignment into three diet groups

• Meal provision: prepackaged meals delivered to homes to improve adherence

• Calorie control and weight plateau:

  • Initial calorie reduction → weight loss in all groups
  • After reaching ~10–11% weight loss, calories adjusted to stabilize weight (prevent further weight loss)

• Duration: about 5 months

---

Key findings (scientific results)

Liver fat

• All diets reduced liver fat, but the magnitude differed:
  • Mediterranean & low-fat plant-forward: ~45% reduction in liver fat
  • Keto: ~68% reduction
• Implied conclusion: very low-carb keto produced extra liver-fat improvement beyond the other diets under calorie-matched, weight-stabilized conditions.

Insulin resistance (tissue-specific)

• Muscle insulin resistance: improved similarly across all groups
• Liver insulin resistance: keto improved ~2–3× more than the other diets
• Fasting glucose:
  • Improved on all diets, but more on keto
  • Keto drop described: ~12 points
  • Mediterranean/low-fat: ~6 points (about 2× more improvement)

Prediabetes remission (“reversed”)

• By end of trial:
  • Low-fat plant-forward: 7% no longer prediabetic
  • Mediterranean: 29% no longer prediabetic
  • Keto: 50% no longer prediabetic

Inflammation

• Inflammatory markers decreased more on keto (specific markers not listed)

apoB (heart disease risk marker)

• apoB decreased across diets:
  • Low-fat: ~9 points
  • Mediterranean: ~15 points
  • Keto: ~6 points
• However, differences were not statistically significant, so the video concludes no clear “winner” for apoB in this trial.
• Dietary detail mentioned: the keto version was not “avocado-and-walnut keto”; it included bacon/sausage/red meat, plus fish and nuts/seeds.

---

How the video connects this trial to other research (conflict & reconciliation)

• The video contrasts with a 2022 trial described as:

  • Carbohydrate difference: 40% vs 10% of calories (4× difference)
  • Calories matched and weight loss matched
  • Liver fat reduction was similar (curves overlapped)

• Proposed explanations for differing results:

  • Carb “threshold/range” hypothesis
    • Little difference from 40% → 10%
    • Extra effect may appear below 10% (ketogenic range)
    • Possible mechanism suggested: total insulin exposure over 24 hours and hormone effects on liver metabolism
  • Population/participant susceptibility hypothesis
    • This newer trial required pre-diabetes inclusion; the older trial did not
    • Very-low-carb benefits might be specific to a sicker subgroup
  • Protein vs carb confounding hypothesis
    • In this new trial, keto group received more protein:
      • ~23% protein (keto) vs ~15% protein (Mediterranean & low-fat)
    • In the 2022 trial, protein was matched across high- vs low-carb diets
    • Therefore, benefits might be driven by higher protein, not carbs
    • Suggested test: run keto vs Mediterranean matched for protein to see if keto’s advantages disappear

---

Takeaways emphasized in the subtitles

• All diets improved health metrics, but keto (very low-carb, high-fat, and higher protein in this study) produced greater liver-focused improvements in this population.
• Scale weight is not the whole story: internal metabolic outcomes can diverge even with matched weight loss.
• Sustainability matters most: the “best” diet is the one people can adhere to long-term.

---

Researchers or sources featured

• No specific researchers, institutions, or publication titles/names are provided in the subtitles excerpt.